naltrexone has been researched along with Movement Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, JA; Clesse, D; Diaz, J; Kieffer, BL; Le Merrer, J; Meirsman, AC; Pellissier, LP | 1 |
| Kim, A; Kornetsky, C; Sax, DS | 1 |
2 other study(ies) available for naltrexone and Movement Disorders
| Article | Year |
|---|---|
Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist.
Topics: Amygdala; Animals; Anxiety; Corpus Striatum; Dendrites; Dopamine; Female; Hippocampus; Male; Mice, Inbred C57BL; Mice, Knockout; Movement Disorders; Naltrexone; Narcotic Antagonists; Receptors, G-Protein-Coupled; Receptors, Opioid, delta; Receptors, Opioid, mu; Serotonin; Spatial Learning | 2016 |
Lack of hepatotoxicity with naltrexone treatment.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Humans; Huntington Disease; Liver Function Tests; Middle Aged; Movement Disorders; Naltrexone | 1994 |